| 000 | 01825 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516173846.0 | ||
| 264 | 0 | _c20140604 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1365-2249 | ||
| 024 | 7 |
_a10.1111/cei.12216 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBridgeman, J S | |
| 245 | 0 | 0 |
_aCD3ΞΆ-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cFeb 2014 |
||
| 300 |
_a258-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _xmetabolism |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aCD3 Complex _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoreceptor Tyrosine-Based Activation Motif _xgenetics |
| 650 | 0 | 4 |
_aImmunotherapy, Adoptive _xmethods |
| 650 | 0 | 4 | _aJurkat Cells |
| 650 | 0 | 4 |
_aLectins, C-Type _xmetabolism |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTranscriptional Activation _xgenetics |
| 700 | 1 | _aLadell, K | |
| 700 | 1 | _aSheard, V E | |
| 700 | 1 | _aMiners, K | |
| 700 | 1 | _aHawkins, R E | |
| 700 | 1 | _aPrice, D A | |
| 700 | 1 | _aGilham, D E | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 175 _gno. 2 _gp. 258-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cei.12216 _zAvailable from publisher's website |
| 999 |
_c23162817 _d23162817 |
||